Researchers have defined a new genetic disease caused by a mutation in the IVNS1ABP gene. The condition marks a rare ...
Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...
Scientists at Sanford Burnham Prebys Medical Discovery Institute and an international team of collaborators have defined a new genetic disease marked by premature aging and deficits in brain function.
Explore the implications of the IVNS1ABP gene in a new genetic disease linked to premature aging and neurological decline.
In the intricate regulation of inflammation, metabolic reprogramming and posttranslational modification (PTM) have emerged as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results